Will Investments in Large-Scale Prospective Cohorts and Biobanks Limit Our Ability to Discover Weaker, Less Common Genetic and Environmental Contributors to Complex Diseases?

Increasing the size of prospective cohorts and biobanks is one approach to discovering previously unknown contributors to complex diseases, but it may come at the price of concealing contributors that are less common across all the participants in those larger studies and of limiting hypothesis gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Foster, Morris W., Sharp, Richard R.
Formato: Texto
Lenguaje:English
Publicado: National Institute of Environmental Health Sciences 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1277853/
https://www.ncbi.nlm.nih.gov/pubmed/15687047
http://dx.doi.org/10.1289/ehp.7343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1277853/
https://www.ncbi.nlm.nih.gov/pubmed/15687047
http://dx.doi.org/10.1289/ehp.7343

Ejemplares similares